SCHEMBL6262189

SCHEMBL6262189

CC(O)CN=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14308877 1.00
SCHEMBL12020188 1.00
SCHEMBL13970891 0.75
SCHEMBL19383703 0.75
SCHEMBL14574324 0.75
SCHEMBL14404814 0.72 ALDH1A1 (0.32)
SCHEMBL528388 0.72
SCHEMBL9190329 0.72 TSHR (0.44)
SCHEMBL1536086 0.72
SCHEMBL12154385 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100591744-C Oil gas well fracturing fluid for stratum of high temperature of 180-200 DEG C UNIV SOUTHWEST PETROLEUM 2010-02-24 CN claimed
CN-101475798-A Oil and gas well fracturing fluid for 180-200 DEG C high temperature strata UNIV SOUTHWEST PETROLEUM (CN) 2009-07-08 CN claimed
EP-1069879-B1 ABSORBENT STRUCTURE AND PRODUCT BASED ON RAW MATERIALS HAVING A HIGH DEGREE OF RENEWABILITY SCA HYGIENE PROD AB (SE) 2004-06-16 EP claimed
EP-3915976-A1 COMPOUND AND METHOD FOR PRODUCING COMPOUND FUJIFILM Corporation (JP) 2021-12-01 EP disclosed
WO-2019148043-A1 COMPOUNDS FOR THE TREATMENT OF KINASE-DEPENDENT DISORDERS EXELIXIS, INC. (US) 2019-08-01 WO disclosed
EP-2960333-B1 COMPOSITION FOR INHIBITING GENE EXPRESSION AND USES THEREOF IDERA PHARMACEUTICALS INC (US) 2017-10-04 EP disclosed
US-9737527-B2 Biopolymer drug loading method SOUTH DAKOTA BOARD OF REGENTS (US) 2017-08-22 US disclosed
EP-3192515-A1 PHARMACEUTICAL COMPOSITION COMPRISING 7BETA- HYDROXYCHOLESTEROL SUITABLE FOR INTRAVENOUS ADMINISTRATION Immunopharm AG (LI) 2017-07-19 EP disclosed
EP-2982679-A1 IMMUNE REGULATORY OLIGONUCLEOTIDE (IRO) COMPOUNDS TO MODULATE TOLL-LIKE RECEPTOR BASED IMMUNE RESPONSE Idera Pharmaceuticals, Inc. (US) 2016-02-10 EP disclosed
CN-104619676-A Hydrophobing dispersion gel having reduced active ingredient content, method for the production thereof, and use thereof for the hydrophobing of mineral materials IONYS AG 2015-05-13 CN disclosed
WO-2015060657-A1 A METHOD FOR PREPARING AN INTERMEDIATE OF IOPROMIDE DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-30 WO disclosed
EP-2112157-A1 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses Academisch Ziekenhuis Leiden (NL) 2009-10-28 EP disclosed
US-7473843-B2 Magnetic resonance imaging coated assembly BIOPHAN TECHNOLOGIES, INC. (US) 2009-01-06 US disclosed
US-20080268036-A1 Co-processing of active pharmaceutical/nutraceutical ingredients JRS PHARMA (US) 2008-10-30 US disclosed
US-7314621-B2 Gene ecodeing protein; activation; cloning; DNA libraries from rodents KYOTO UNIVERSITY (JP) 2008-01-01 US disclosed
WO-2005080319-A1 HYDRAZINO ALCOHOL DERIVATIVES USEFUL AS INHIBITORS OF COPPER-CONTAINING AMINE OXIDASES BIOTIE THERAPIES CORPORATION (FI) 2005-09-01 WO disclosed
EP-0068520-B1 BUILT LIQUID DETERGENT COMPOSITIONS CONTAINING TERNARY ACTIVE SYSTEMS THE PROCTER &amp; GAMBLE COMPANY (US) 1986-12-03 EP disclosed
EP-0094119-B1 STABLE LIQUID DETERGENT COMPOSITIONS THE PROCTER &amp; GAMBLE COMPANY (US) 1986-11-12 EP disclosed
EP-0087914-B1 DETERGENT COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 1986-10-08 EP disclosed
EP-0052972-A1 Fabric conditioning article, method of manufacturing same, and method of conditioning clothes therewith BEECHAM INC. (US) 1982-06-02 EP disclosed